Medication info
Etracetsem Tablet

Etracetsem Tablet

Prescription medicationTabletOral
Ingredient · strength
Acetaminophen›162.5mg / 1 tabletTramadol Hydrochloride›18.75mg / 1 tablet
Manufacturer / importer
Introbio Pharma Co., Ltd.
Appearance
Pale yellow rectangular film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201706582 · Approved 2017.08.14 · Insurance code 052400500

Summary

Main use
Relief of moderate to severe acute and chronic pain
Who takes it
Adults · Children
Adult dose
Elderly patients Administer the usual adult dose. However, when tramadol is given orally to patients aged 75 years and older, the elimination half-life of tramadol increased by 17%; therefore, administer this medicine at intervals of at least 6 hours. Patients with renal impairment In patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Use is not recommended in patients with severe renal impairment (creatinine clearance below 10ml/min). Since tramadol is removed very slowly by hemodialysis and filtration, redosing this medicine after dialysis is not necessary to maintain the analgesic effect. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this medicine to patients with severe hepatic impairment.
Child dose
Pediatric patients aged 12 years and older and adults: The dose should be adjusted according to the severity of the patient's pain and response to treatment. The recommended initial dose is 4 tablets; thereafter, doses should be spaced at least 6 hours apart, and no more than 16 tablets should be taken in 1 day. Use the lowest effective dose for the shortest possible duration. Do not use this medicine for longer than necessary. If long-term treatment is required because of the nature and severity of the condition, conduct regular monitoring to determine whether treatment with this medicine should be continued.

Ingredients

Manufacturer
Introbio Pharma Co., Ltd.

Efficacy & effects

Relief of moderate to severe acute and chronic pain

  • Moderate to severe acute pain
  • chronic pain
View approved original text

This medication is used to relieve acute and chronic pain ranging from moderate to severe.

How to take

Adult dose

Elderly patients Administer the usual adult dose. However, when tramadol is given orally to patients aged 75 years and older, the elimination half-life of tramadol increased by 17%; therefore, administer this medicine at intervals of at least 6 hours. Patients with renal impairment In patients with moderate renal impairment (creatinine clearance 10-30ml/min), extend the dosing interval to 12 hours. Use is not recommended in patients with severe renal impairment (creatinine clearance below 10ml/min). Since tramadol is removed very slowly by hemodialysis and filtration, redosing this medicine after dialysis is not necessary to maintain the analgesic effect. Patients with hepatic impairment Carefully consider extending the dosing interval in patients with moderate hepatic impairment. Do not administer this medicine to patients with severe hepatic impairment.

Child dose

Pediatric patients aged 12 years and older and adults: The dose should be adjusted according to the severity of the patient's pain and response to treatment. The recommended initial dose is 4 tablets; thereafter, doses should be spaced at least 6 hours apart, and no more than 16 tablets should be taken in 1 day. Use the lowest effective dose for the shortest possible duration. Do not use this medicine for longer than necessary. If long-term treatment is required because of the nature and severity of the condition, conduct regular monitoring to determine whether treatment with this medicine should be continued.

Precautions

This medication may place a burden on the liver, so individuals who consume alcohol in amounts exceeding a certain daily limit should consult a physician or pharmacist before taking it. If any skin rashes or allergic reactions occur during treatment, therapy should be discontinued immediately, and medical advice should be sought. Tramadol, one of the components of this medication, may increase the risk of seizures; thus, patients with a history of seizures or at risk of seizures should take this medication with caution. In patients with severe bronchial asthma, this medication should be administered under the supervision of healthcare professionals due to the risk of respiratory depression. Concomitant use of this medication with other central nervous system depressants or alcohol may lead to dangerous side effects such as severe drowsiness or respiratory depression, so such combinations should be avoided. Patients with head injuries or elevated intracranial pressure may experience exacerbated symptoms when taking this medication and should proceed with caution. This medication can lead to dependence; therefore, when taken for extended periods, dosage and duration should be adjusted according to a physician's instructions. Patients with impaired liver function must consult a physician before taking this medication, and should not exceed the recommended dosage due to the risk of liver damage. Patients with specific genetic metabolic characteristics may experience severe respiratory depression after taking this medication, necessitating closer observation. This medication should not be used in children under 12 years of age or in adolescents under 18 who have undergone specific surgeries. Patients with sleep apnea or at risk of hypoxemia should be periodically assessed for symptom exacerbation after taking this medication. This medication can cause hyponatremia, so elderly patients or those at risk of hyponatremia should monitor serum sodium levels. Patients allergic to any ingredients of this medication, experiencing severe respiratory depression, severe liver or kidney impairment, or those taking specific medications are prohibited from taking it. During treatment, abrupt cessation should be avoided, and dosage should be gradually reduced, as withdrawal symptoms may arise. Pregnant or nursing women should consult a physician before taking this medication, and it is safer not to take it while breastfeeding. Caution should be exercised when driving or operating machinery, as this medication may cause drowsiness or dizziness.

Side effects

Liver damage, acute generalized pustular exanthema, Stevens-Johnson syndrome, toxic epidermal necrolysis, seizures, anaphylactic reactions, respiratory depression, deep sedation, coma, death, carbon dioxide retention, respiratory inhibition, loss of appetite, insomnia, depression, dizziness, headache, drowsiness, nausea, vomiting, constipation, dry mouth, diarrhea, indigestion, abdominal pain, abdominal discomfort, flatulence, pruritus, sweating, rash, fatigue, flushing, urticaria, hypersensitivity, hypoglycemia, anxiety, nervous irritability, emotional instability, euphoria, decreased libido, sleep disorders, disorientation, loss of directional sense, agitation, abnormal dreams, drug abuse, hallucinations, withdrawal syndrome, migraine, somnolence, sensory decrease, tremors, sensory disturbances, attention deficit, syncope, memory impairment, psychomotor hyperactivity, sedation, amnesia, perceptual disturbances, convulsions, blurred vision, visual impairment, pupil constriction, dizziness, tinnitus, ear discomfort, palpitations, tachycardia, hypertension, hypotension, dyspnea, dry throat, increased liver enzymes, generalized pruritus, cold sweats, urinary disorders, erectile dysfunction, weakness, chest pain, emotional irregularity, chills, chest discomfort, malaise, thirst, irritability, heat sensation, weight loss, increased serum creatinine, anaphylaxis reaction, Stevens-Johnson syndrome, toxic epidermal necrolysis, emotional instability, delirium, suicidal thoughts, muscle hypertonicity, movement disorders, serotonin syndrome, speech disorders, mydriasis, orthostatic hypotension, hepatitis, gait disturbances, prolonged prothrombin time, thrombocytopenia, agranulocytosis, blood disorders, hyponatremia, syndrome of inappropriate antidiuretic hormone secretion, fixed rash, weakness, fever, edema, rigidity, syncope, congestive heart failure, confusion, muscle tension, migraine exacerbation, involuntary muscle contractions, exertional dyspnea, cough, bronchitis, urinary retention, frequent urination, abnormal kidney function tests, oliguria, increased sweating, dysphagia, tongue swelling, increased salivation, progression of rectal cancer, progression of esophageal cancer, progression of gastric cancer, paralytic ileus, hiccups, cholecystitis, tinnitus, chills, buttock pain, thigh pain, allergic rhinitis, epistaxis, abnormal vision, progression of biliary tract cancer, foreign body sensation in the eye, progression of liver cancer, abnormal liver function, nausea, constipation, vomiting, indigestion, abdominal pain, dry mouth, diarrhea, drowsiness, insomnia, loss of appetite, anxiety, depression, nervous irritability, emotional instability, hallucinations, depersonalization, anemia, decreased hemoglobin, decreased red blood cells, decreased white blood cells, increased white blood cells, palpitations, arrhythmia, exacerbation of hypertension, aortic stenosis, gastrointestinal bleeding, increased cholesterol, weight loss, tinnitus, chills, buttock pain, thigh pain, allergic rhinitis, epistaxis, abnormal vision, progression of biliary tract cancer, foreign body sensation in the eye, progression of liver cancer, abnormal liver function, nausea, dizziness, confusion, migraine, speech disorders, loss of consciousness, recurrence of myocardial infarction, hypotension, disorientation, multiple organ failure, anaphylaxis, intentional overdose, chest discomfort, withdrawal symptoms, anxiety, sweating, rigidity, pain, diarrhea, upper respiratory syndrome, hyperventilation, agitation, hyperactivity, panic attacks, severe anxiety, hallucinations, perceptual disturbances, tinnitus, abnormal central nervous system reactions, paralytic ileus, cholecystitis, abnormal kidney function tests, increased salivation, gastrointestinal bleeding, QT prolongation, myocardial infarction

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air and moisture from entering, and it is recommended to keep it in a cool place at 25 degrees Celsius or below.

Appearance and packaging

Appearance

Pale yellow rectangular film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.